A comparison of dsm-iv and dsm-5 panel members' financial associations with industry: A pernicious problem persists

PLoS Medicine

Volumn 9, Issue 3, 2012, Pages

  Cosgrove, Lisa ^a,b   Krimsky, Sheldon ^c  

^a HARVARD UNIVERSITY   (United States)

^b UNIVERSITY OF MASSACHUSETTS BOSTON   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONFLICT OF INTEREST; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG INDUSTRY; ECONOMIC ASPECT; FUNDING; HEALTH CARE POLICY; HUMAN; MEDICAL SOCIETY; ORGANIZATION AND MANAGEMENT; ECONOMICS; INDUSTRY;

CONFLICT OF INTEREST; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; INDUSTRY;

EID: 84858961309     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001190     Document Type: Article

References (31)

1. Tsai AC, Rosenlicht NZ, Jureidini JN, Parry PI, Spielmans GI, et al. (2011) Aripiprazole in the maintenance treatment of bipolar disorder: a critical review of the evidence and its dissemination into the scientific literature. PLoS Med 8: e1000434 doi:10.1371/journal.pmed.1000434.
2. Cosgrove L, Bursztajn HJ, Krimsky S, Anaya M, Walker J, (2009) Conflicts of interest and disclosure in the American Psychiatric Association's Clinical Practice Guidelines. Psychother Psychosom 78: 228-232.
3. Lacasse JR, Leo J, (2010) Ghostwriting at elite academic medical centers in the United States. PLoS Med 7: e1000230 doi:10.1371/journal.pmed.1000230.
4. Roehr B, (2011) Professor files complaint of scientific misconduct over allegation of ghostwriting. BMJ 343: d4458 doi:10.1136/bmj.d4458.
5. Harris G, Carey B, (2008, June 8) Researchers fail to reveal full drug pay. New York Times. Available: http://www.nytimes.com/2008/06/08/us/08conflict.html?pagewanted=all. Accessed 11 January 2012.
6. Heres S, Davis J, Maino K, Jetzinger E, Kissling W, et al. (2006) Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: An exploratory analysis of head-to-head comparison studies of second-generation antipsychotics. Am J Psychiatry 163: 185-194.
7. Perlis R, Perlis C, Wu Y, Hwang C, Joseph M, et al. (2005) Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry. Am J Psychiatry 162: 1957-1960.
8. Angell M, (2010) The illusions of psychiatry. New York Rev Books 58: 20-22.
9. Frances A, (2010) Opening Pandora's box: The 19 worst suggestions for DSM5. Psychiatric Times 27: 9.
10. World Health Organization (1992) International statistical classification of disease and related health problems, Tenth Revision (ICD-10) Geneva World Health Organization.
11. American Psychiatric Association (2007, July 23) APA names DSM-V task force members: leading experts to revise handbook for diagnosing mental disorders [Press release #07-57]. Available: http://www.dsm5.org/Newsroom/Documents/07-57%20APA%20Announces%20DSM%20Task%20Force%20Members.pdf. Accessed 16 November 2011.
12. Bekelman J, Li Y, Gross C, (2003) Scope and impact of financial conflicts of interest in biomedical research: A systematic review. JAMA 289: 454-465.
13. Stelfox H, Chua G, O'Rourke K, Detsky A, (1998) Conflict of interest in the debate over calcium-channel antagonists. N Engl J Med 338: 101-106.
14. Kjaergard L, Als-Nielsen B, (2002) Association between competing interests and authors' conclusions: Epidemiological study of randomised clinical trials published in the BMJ. BMJ 325: 249.
15. Krimsky S, (2010) Combating the funding effect in science: What's beyond transparency? Stanford Law Policy Rev XXI: 101-123.
16. National Research Council (2009) Conflict of interest in medical research, education, and practice [consensus report]. Lo B, Field MJ, eds. Washington, DC National Academies Press Available: http://www.iom.edu/Reports/2009/Conflict-of-Interest-in-Medical-Research-Education-and-Practice.aspx. Accessed 11 January 2012.
17. Matheson A, (2008) Corporate science and the husbandry of scientific and medical knowledge by the pharmaceutical industry. Bio Societies 3: 355-382.
18. Cosgrove L, Bursztajn HJ, Krimsky S, (2009) Developing unbiased diagnostic and treatment guidelines in psychiatry. N Eng J Med 360: 2035-2036.
19. Pilecki BC, Clegg JW, McKay D, (2011) The influence of corporate and political interests on models of illness in the evolution of the DSM. Eur Psychiatry 26: 194-200.
20. Jørgensen AW, Hilden J, Gøtzsche PC, (2006) Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review. BMJ 331: 782-785.
21. Bhandari M, Busse JW, Jackowski D, Montori VM, Schünemann H, et al. (2004) Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. Can Med Assoc J 170: 477-480.
22. Lesser LI, Ebbeling CB, Goozner M, Wypij D, Ludwig DS, (2007) Relationship between funding source and conclusion among nutrition-related scientific articles. PLoS Med 4: e5 doi:10.1371/journal.pmed.0040005.
23. Cain DM, Lowenstein G, Moore DA, (2005) The dirt on coming clean: Perverse effects of disclosing conflicts of interest. J Legal Stud 31: 1-25.
24. Cosgrove L, Krimsky S, Vijayaraghavan M, Schneider L, (2006) Financial ties between DSM-IV panel members and the pharmaceutical industry. Psychother Psychosom 75: 154-160.
25. Lexchin J, O'Donovan O, (2010) Prohibiting or 'managing' conflict of interest?: A review of policies and procedures in three European drug regulation agencies. Soc Sci Med 70: 643-647.
26. Katz D, Caplan AL, Merz JF, (2003) All gifts large and small: Toward an understanding of the ethics of pharmaceutical industry gift-giving. Am J Bioeth 3: 39-46.
27. Mather C, (2005) The pipeline and the porcupine: Alternate metaphors of the physician-industry relationship. Soc Sci Med 60: 1323-1334.
28. Mauss M, (1967) The gift: Forms and functions of exchange in archaic societies (I. Cunnison, Trans.) New York W.W. Norton Co.
29. Mendelson TB, Meltzer M, Campbell EG, Caplan AL, Kirkpatrick JN, (2011) Conflicts of interest in cardiovascular clinical practice guidelines. Arch Intern Med 171: 577-584 doi:10.1001/archinternmed.2011.96.
30. Institute of Medicine (2011) Clinical practice guidelines we can trust: Report brief Washington (DC) National Academies Press Available: http://www.iom.edu/~/media/Files/Report%20Files/2011/Clinical-Practice-Guidelines-We-Can-Trust/Clinical%20Practice%20Guidelines%202011%20Report%20Brief.pdf. Accessed 30 March 2011.
31. American Psychiatric Association (2010) DSM-5 Development: Frequently asked questions. Available: http://www.dsm5.org/about/pages/faq.aspx. Accessed 30 September 2011.